> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# OMB Asked to Extend Info Collection on FDA Drug Communications
- URL: https://www.fdaweb.com/omb-asked-to-extend-info-collection-on-fda-drug-communications/
- Published: 2017-12-13T12:00:00.000Z
- Updated: 2026-09-14T23:08:20.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140334

*Federal Register* notice: FDA is sending to OMB an information collection extension request for “Data To Support Drug Product Communications as Used by FDA: OMB Control Number 0910-0695.” The information collection is used to form opinions on a specific topic and as a qualitative research tool for two major purposes: To obtain information that is useful for developing variables and measures for formulating the basic objectives of risk communication campaigns, and to assess the potential effectiveness of messages and materials in reaching and successfully communicating with their intended audiences. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-12-13/pdf/2017-26795.pdf?ref=fdaweb.com).